And ARG-007 is administered IV so of course it crosses the blood-brain barrier. It has promising pre-clinical work in stroke, TBI, HIE, hypoxic damage from heart attack, parkinsons, alzheimers.
.
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-6
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.003(4.76%) |
Mkt cap ! $12.02M | |||
| Open | High | Low | Value | Volume |
| 6.3¢ | 6.6¢ | 5.7¢ | $66.11K | 1.090M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 101030 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.6¢ | 205 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.3¢ |
Change
0.003 ( 1.56 %) |
||||
| Open | High | Low | Volume | ||
| 6.3¢ | 6.8¢ | 5.7¢ | 547089 | ||
| Last updated 15.38pm 14/06/2024 ? | |||||
| NYR (ASX) Chart |